Resistance to Antivirals

Balfour, 1994, Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections, J Acquir Immune Defic Syndr, 7, 254 Bean, 1989, Biologic potential of amantadine-resistant influenza A virus in an avian model, J Infect Dis, 159, 1050, 10.1093/infdis/159.6.1050 Belshe, 1989, Resistance of influenza A virus to amantadine and rimantadine: Results of one decade of surveillance, J Infect Dis, 159, 430, 10.1093/infdis/159.3.430 Belshe, 1988, Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection, J Virol, 62, 1508, 10.1128/JVI.62.5.1508-1512.1988 Birch, 1990, Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome, J Infect Dis, 162, 731, 10.1093/infdis/162.3.731 Biron, 1982, Selection and preliminary characterization of acyclovir-resistant mutants of varicella zoster virus, Am J Med, 73, 383, 10.1016/0002-9343(82)90128-0 Boivin, 1994, Phenotypic and genotypic characterization of acyclovir-resistant varicella-zoster viruses isolated from persons with AIDS, J Infect Dis, 170, 68, 10.1093/infdis/170.1.68 Boivin, 1993, Acyclovir susceptibilities of herpes simplex virus strains isolated from solid organ transplant recipients after acyclovir or ganciclovir prophylaxis, Antimicrob Agents Chemother, 37, 357, 10.1128/AAC.37.2.357 Boivin, 1993, Ganciclovir susceptibilities to cytomegalovirus (CMV) isolates from solid organ transplant recipients with CMV viremia after antiviral prophylaxis, J Infect Dis, 168, 332, 10.1093/infdis/168.2.332 Boucher, 1992, Ordered appearance of zidovudine resistant mutations during treatment of 18 human immunodeficiency virus-positive subjects, J Infect Dis, 165, 105, 10.1093/infdis/165.1.105 Chow, 1993, Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy, Nature, 361, 650, 10.1038/361650a0 Christophers, 1986, Clinical resistance to acyclovir of herpes simplex virus infections in immunocompromised patients, 18, 121 Coen, 1991, The implications of resistance to antiviral drugs for herpesvirus drug targets and drug therapy, Antiviral Res, 15, 287, 10.1016/0166-3542(91)90010-O Conlon, 1994, Heterosexual transmission of human immunodeficiency virus type 1 variants associated with zidovudine resistance, J Infect Dis, 169, 411, 10.1093/infdis/169.2.411 Crumpacker, 1982, Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir, N Engl J Med, 306, 343, 10.1056/NEJM198202113060606 Darby, 1992, The clinical significance of antiviral drug resistance, Res Virol, 143, 116, 10.1016/S0923-2516(06)80091-9 Degelau, 1992, Amantadine-resistant influenza A in a nursing facility, Arch Intern Med, 152, 390, 10.1001/archinte.1992.00400140128027 Drew, 1991, Prevalence of CMV resistance in patients receiving ganciclovir for serious CMV infection, J Infect Dis, 163, 716, 10.1093/infdis/163.4.716 Elion, 1977, Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine, Proc Nat Acad Sci U S A, 74, 5716, 10.1073/pnas.74.12.5716 Englund, 1990, Herpes simplex resistant to acyclovir: a study in a tertiary care center, Ann Intern Med, 112, 416, 10.7326/0003-4819-76-3-112-6-416 Erice, 1994, Resistance of human immunodeficiency virus type 1 to antiretroviral agents: A review, Clin Infect Dis, 18, 149, 10.1093/clinids/18.2.149 Erice, 1989, Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients, N Engl J Med, 320, 289, 10.1056/NEJM198902023200505 Erice, 1993, Brief report: Primary infection with zidovudine-resistant human immunodeficiency virus type 1, N Engl J Med, 328, 1163, 10.1056/NEJM199304223281605 Erlich, 1989, Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS), Ann Intern Med, 110, 710, 10.7326/0003-4819-110-9-710 Erlich, 1989, Acyclovir-resistant herpes simplex virus in patients with the acquired immunodeficiency syndrome, N Engl J Med, 320, 293, 10.1056/NEJM198902023200506 Field, 1994, “The end of innocence” revisited: resistance of herpesviruses to antiviral drugs, Clin Microbiol Rev, 7, 1, 10.1128/CMR.7.1.1 Field, 1986, Pathogenicity of herpes simplex virus mutants containing drug resistance mutations in the viral DNA polymerase gene, J Virol, 60, 286, 10.1128/JVI.60.1.286-289.1986 Field, 1978, The pathogenicity of thymidine kinase deficient mutants of herpes simplex virus in mice, Journal of Hygiene, 81, 267, 10.1017/S0022172400025109 Fitzgibbon, 1994, Tranmission from one child to another of human immunodeficiency virus type 1 with a zidovudine-resistance mutation, N Engl J Med, 329, 18351841 Freifeld, 1991, Resistance of viruses to antiviral drugs, Annu Rev Med, 42, 247, 10.1146/annurev.me.42.020191.001335 Gateley, 1990, Herpes simplex virus type 2 meningoencephalitis resistant to acyclovir in a patient with AIDS, J Infect Dis, 161, 711, 10.1093/infdis/161.4.711 Gnaan, 1994, New antivirals with activity against varicella-zoster virus, Ann Neurol, 34, S69, 10.1002/ana.410350720 Hall, 1987, Children with influenza A infection: treatment with rimantadine, Pediatrics, 80, 275, 10.1542/peds.80.2.275 Hayden, 1992, Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine, Curr Top Microbiol Immunol, 176, 119 Hayden, 1989, Emergence and apparent transmission of rimantadine-resistant influenza A virus in families, N Engl J Med, 321, 1696, 10.1056/NEJM198912213212502 Hill, 1991, In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus, Antimicrob Agents Chemother, 35, 2322, 10.1128/AAC.35.11.2322 Jacobson, 1994, Phase I trial of valaciclovir, the L-valyl ester of acyclovir, in patients with advanced human immunodeficiency virus disease, Antimicrob Agents Chemother, 38, 1534, 10.1128/AAC.38.7.1534 Knox, 1991, Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient, Lancet, 337, 1292, 10.1016/0140-6736(91)92965-5 Kost, 1993, Brief report: Recurrent acyclovir-resistant genital herpes in an immunocompetent patient, N Engl J Med, 329, 1777, 10.1056/NEJM199312093292405 Lalezari, 1994, Treatment of intravenous (S)-1-[hydroxy-2-(phosphonylmethoxy)propyl]-cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS, J Infect Dis, 170, 570, 10.1093/infdis/170.3.570 Lehrman, 1986, Extended acyclovir therapy for herpes genitalis: Changes in virus sensitivity and strain variation, J Antimicrob Chemother, 18, 85, 10.1093/jac/18.Supplement_B.85 Leibovitz, 1992, Chronic varicella zoster in a child infected with human immunodeficiency virus: Case report and review of the literature, Cutis, 49, 27 Ljungman, 1990, Acyclovir-resistant herpes simplex virus causing pneumonia after marrow transplantation, J Infect Dis, 162, 244, 10.1093/infdis/162.1.244 Lurain, 1994, Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir, J Virol, 68, 4427, 10.1128/JVI.68.7.4427-4431.1994 Lyall, 1994, Acyclovir resistant varicella zoster and HIV infection, Arch Dis Child, 70, 133, 10.1136/adc.70.2.133 Mast, 1991, Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2), Am J Epidemiol, 134, 988, 10.1093/oxfordjournals.aje.a116184 Murphy, 1992, Topical trifluridine for mucocutaneous acyclovir-resistant herpes simplex II in AIDS patient [letter], Lancet, 340, 1040, 10.1016/0140-6736(92)93055-R Norris, 1988, Severe progressive herpetic whitlow caused by an acyclovir-resistant virus in a patient with AIDS, J Infect Dis, 157, 209, 10.1093/infdis/157.1.209 Nyquist, 1994, Acyclovir-resistant neonatal herpes simplex virus infection of the larynx, J Pediatr, 124, 967, 10.1016/S0022-3476(05)83194-4 Ogino, 1993, Development and significance of zidovudine resistance in children infected with human immunodeficiency virus, J Pediatr, 123, 1, 10.1016/S0022-3476(05)81529-X Pahwa, 1988, Continuous varicella zoster virus infection associated with acyclovir resistance in a child with AIDS, JAMA, 260, 2879, 10.1001/jama.1988.03410190127035 Parris, 1982, Herpes simplex virus variants resistant to high concentrations of acyclovir exist in clinical isolates, Antimicrob Agents Chemother, 22, 71, 10.1128/AAC.22.1.71 Pizzo, 1994, Antiretroviral therapy for infection due to human immunodeficiency virus in children, Clin Infect Dis, 19, 177, 10.1093/clinids/19.1.177 Richman, 1993, Resistance of clinical isolates of human immunodeficiency virus to antiretroviral agents, Antimicrob Agents Chemother, 37, 1207, 10.1128/AAC.37.6.1207 Richman, 1994, Resistance to AZT and ddC during long-term combination therapy in patients with advanced infection with human immunodeficiency virus, J Acquir Immune Defic Syndr, 7, 135 Rodriguez, 1994, Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: A double-blind, multicenter, placebo-controlled trial, J Pediatr, 125, 129, 10.1016/S0022-3476(94)70139-3 Safrin, 1993, In vitro activity of penciclovir against clinical isolates of acyclovir-resistant and foscarnet-resistant herpes simplex virus, Antimicrob Agents Chemother, 37, 2241, 10.1128/AAC.37.10.2241 Sacks, 1989, Progressive esophagitis from acyclovir-resistant herpes simplex: Clinical roles for DNA polymerase mutants and viral heterogeneity?, Ann Intern Med, 111, 893, 10.7326/0003-4819-111-11-893 Safrin, 1990, Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: Preliminary data, J Infect Dis, 11, 1078, 10.1093/infdis/161.6.1078 Safrin, 1991, Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella zoster virus infection, Ann Intern Med, 115, 19, 10.7326/0003-4819-115-1-19 Safrin, 1991, A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome, N Engl J Med, 325, 551, 10.1056/NEJM199108223250805 Safrin, 1994, Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility results for isolates of herpes simplex virus from human immunodeficiency virus-infected patients, Antimicrob Agents Chemother, 38, 1246, 10.1128/AAC.38.6.1246 Safrin, 1994, Focarnet-resistant herpes simplex virus infection in patients with AIDS, J Infect Dis, 169, 193, 10.1093/infdis/169.1.193 Shafer, 1994, Combination therapy with zidovudine and didanoside selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations, J Infect Dis, 169, 722, 10.1093/infdis/169.4.722 Sibrack, 1982, Pathogenicity of acyclovir-resistant herpes simplex type 1 from an immunodeficient child, J Infect Dis, 146, 673, 10.1093/infdis/146.5.673 Smith, 1991, Acyclovir-resistant varicella zoster responsive to foscamet, Arch Dermatol, 127, 1069, 10.1001/archderm.1991.01680060145032 Snoeck, 1994, Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC), Clin Infect Dis, 18, 570578, 10.1093/clinids/18.4.570 Stanat, 1991, Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir, Antimicrob Agents Chemother, 35, 2191, 10.1128/AAC.35.11.2191 St. Clair, 1991, Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase, Science, 253, 1557, 10.1126/science.1716788 Sullivan, 1993, A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivatives, Antimicrob Agents Chemother, 37, 19, 10.1128/AAC.37.1.19 Talarico, 1993, Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolated from patients with AIDS, J Virol, 67, 1024, 10.1128/JVI.67.2.1024-1033.1993 Tatarowicz, 1992, A ganciclovir-resistant clinical isolate of human cytomegalovirus exhibiting cross-resistance to other DNA polymerase inhibitors, J Infect Dis, 166, 904, 10.1093/infdis/166.4.904 Tudor-Williams, 1992, HIV-1 sensitivity to zidovudine and clinical outcome in children, Lancet, 339, 15, 10.1016/0140-6736(92)90140-X Van Voris, 1992, Antivirals for the chemoprophylaxis and treatment of influenza, Seminars in Respiratory Infections, 7, 61 Verdonck, 1993, Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT, Bone Marrow Transplant, 11, 177 Wade, 1983, Frequency and significance of acyclovir resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir, J Infect Dis, 148, 1077, 10.1093/infdis/148.6.1077